Cardiac Action Potential (Phase 1, Phase 2, Phase 3)

📌𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗛𝗲𝗿𝗲:- https://t.me/bhanuprakashdr 📌 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦:-   / drgbhanuprakash   📌𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝗧𝗼 𝗠𝘆 𝗠𝗮𝗶𝗹𝗶𝗻𝗴 𝗟𝗶𝘀𝘁:- https://linktr.ee/DrGBhanuprakash 4 - Cardiac Action Potential (Phase 1, Phase 2, Phase 3) Antiarrhythmic drugs are used to prevent recurrent arrhythmias and restore sinus rhythm in patients with cardiac arrhythmias. These drugs are classified based on their electrophysiological effect on the myocardium. Antiarrhythmic drugs do not improve the survival of patients with non-life-threatening arrhythmias and may increase mortality, particularly in patients with structural heart disease. They are associated with severe adverse effects, primarily due to their proarrhythmic effects on the myocardium. Patients who have received an intravenous antiarrhythmic should be monitored closely with serial ECGs. Several classes of antiarrhythmics, including beta-blockers, calcium channel blockers, amiodarone, cardiac glycosides, and lidocaine, also have other medical uses, which are discussed in these videos in detail We have 13 videos in this section and these are arranged in numerical order to watch, Hope you like these videos, Thank you and keep watching #antiarrhythmicdrugs #antiarrhythmicagents #drugsofarrhythmias #cvspharmacology #cardiovascularpharmacology #antiarrhythmicpharmacology #pharmacologyneetpg #pharmacologyvideos #pharmacologyfmge #pharmacologyofcvs #class1antiarrhythmicagents #cardiacactionpotential #class3antiarrhythmicagents #quinidine #procainamide #verapamil #diltiazam #phase0blockets #phase1blockers #phase3blockers #cardiacarrhythmias